| 0 (0%) | 01-19 18:52 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.6 |
1-year : | 5.37 |
| Resists | First : | 3.94 |
Second : | 4.6 |
| Pivot price | 3.44 |
|||
| Supports | First : | 3.49 |
Second : | 3.22 |
| MAs | MA(5) : | 3.51 |
MA(20) : | 3.44 |
| MA(100) : | 4.17  |
MA(250) : | 6.09 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 73.3 |
D(3) : | 55.4 |
| RSI | RSI(14): 65.4 |
|||
| 52-week | High : | 11.25 | Low : | 3.22 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ RCEL ] has closed It is unclear right now based on current values. 56.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 48 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 3.94 - 3.96 | 3.96 - 3.98 |
| Low: | 3.43 - 3.45 | 3.45 - 3.47 |
| Close: | 3.87 - 3.9 | 3.9 - 3.93 |
Sat, 17 Jan 2026
AVITA Medical, Inc.'s (NASDAQ:RCEL) Path To Profitability - simplywall.st
Fri, 16 Jan 2026
RCEL Analyst Rating Update: Lake Street Raises Price Target | RC - GuruFocus
Thu, 15 Jan 2026
New Analyst Forecast: $RCEL Given $10 Price Target - Quiver Quantitative
Thu, 15 Jan 2026
AVITA Medical (RCEL): Analyst Lowers Price Target, Maintains Buy Rating | RCEL Stock News - GuruFocus
Thu, 15 Jan 2026
D. Boral Capital Issues Pessimistic Forecast for Avita Medical (NASDAQ:RCEL) Stock Price - MarketBeat
Wed, 14 Jan 2026
RCEL: 2026 guidance targets $80–$85M revenue, driven by clinical innovation and focused execution - TradingView — Track All Markets
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 30 (M) |
| Held by Insiders | 3.02e+007 (%) |
| Held by Institutions | 0.8 (%) |
| Shares Short | 3,020 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -4.003e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | -67.1 % |
| Operating Margin | -53.7 % |
| Return on Assets (ttm) | -36.4 % |
| Return on Equity (ttm) | -1 % |
| Qtrly Rev. Growth | 7.24e+007 % |
| Gross Profit (p.s.) | -7.66 |
| Sales Per Share | 449.56 |
| EBITDA (p.s.) | 3.65241e+007 |
| Qtrly Earnings Growth | -1.9 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -34 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | -29.43 |
| Dividend | 0 |
| Forward Dividend | 3.03e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|